ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 65 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 9.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,058,000 | -49.7% | 461,957 | -41.3% | 0.03% | -59.3% |
| Q3 2014 | $2,102,000 | -38.9% | 787,088 | -14.7% | 0.08% | -45.3% |
| Q2 2014 | $3,441,000 | +17.0% | 922,562 | +161.5% | 0.15% | -21.3% |
| Q4 2013 | $2,942,000 | -22.7% | 352,800 | -14.1% | 0.19% | -23.9% |
| Q3 2013 | $3,806,000 | -2.1% | 410,577 | +3.5% | 0.25% | -5.0% |
| Q2 2013 | $3,888,000 | – | 396,730 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Steamboat Capital Partners, LLC | 817,521 | $414,000 | 0.37% |
| Abingworth LLP | 396,104 | $195,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,638 | $31,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 128,520 | $65,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 949,438 | $481,000 | 0.00% |
| Renaissance Technologies | 908,100 | $460,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $23,000 | 0.00% |
| DEUTSCHE BANK AG\ | 5 | $0 | 0.00% |
| CITIGROUP INC | 10,376 | $5,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 20,037 | $10,000 | 0.00% |